ES2009140A6 - Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen. - Google Patents
Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen.Info
- Publication number
- ES2009140A6 ES2009140A6 ES8700289A ES8700289A ES2009140A6 ES 2009140 A6 ES2009140 A6 ES 2009140A6 ES 8700289 A ES8700289 A ES 8700289A ES 8700289 A ES8700289 A ES 8700289A ES 2009140 A6 ES2009140 A6 ES 2009140A6
- Authority
- ES
- Spain
- Prior art keywords
- crl
- human monoclonal
- antibodies
- cross
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
UN METODO DE PRODUCCION DE ANTICUERPOS MONOCLONALES HUMANOS DE PROTECCION CRUZADA Y DE COMPOSICIONES QUE LOS CONTIENEN. LOS ANTICUERPOS SE OBTIENEN MEDIANTE EL CULTIVO DE LINEAS CELULARES QUE SEGREGAN ANTICUERPOS MONOCLONALES HUMANOS CAPACES DE UNIRSE A MOLECULAS DE DIFERENTES ESPECIES BACTERIANAS Y SU POSTERIOR RECUPERACION. LOS ANTICUERPOS ASI OBTENIDOS PUEDEN FORMULARSE EN COMPOSICIONES FARMACEUTICAS EN COMBINACION CON OTROS ANTICUERPOS, FRACCIONES DE PLASMA O AGENTES ANTIMICROBIANOS. LOS ANTICUERPOS MONOCLONALES ASI OBTENIDOS PROTEGEN CONTRA LOS ATAQUES LETALES DE DIVERSOS GENEROS DE BACTERIAS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82800586A | 1986-02-07 | 1986-02-07 | |
US94449586A | 1986-12-19 | 1986-12-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2009140A6 true ES2009140A6 (es) | 1989-09-01 |
Family
ID=27125154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES8700289A Expired ES2009140A6 (es) | 1986-02-07 | 1987-02-06 | Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen. |
Country Status (28)
Country | Link |
---|---|
US (2) | US5717071A (es) |
JP (1) | JP2645343B2 (es) |
KR (1) | KR870007697A (es) |
CN (1) | CN87102167A (es) |
AT (1) | AT398781B (es) |
BE (1) | BE1000967A5 (es) |
CA (1) | CA1339013C (es) |
CH (1) | CH672072A5 (es) |
DE (1) | DE3703711A1 (es) |
DK (1) | DK63187A (es) |
ES (1) | ES2009140A6 (es) |
FI (1) | FI94489C (es) |
FR (1) | FR2595946B1 (es) |
GB (1) | GB2186592B (es) |
GR (1) | GR870194B (es) |
HK (1) | HK21795A (es) |
HU (1) | HU203583B (es) |
IE (1) | IE59627B1 (es) |
IL (1) | IL81370A (es) |
IT (1) | IT1207589B (es) |
LU (1) | LU86761A1 (es) |
MX (1) | MX9203629A (es) |
NL (1) | NL8700286A (es) |
NO (1) | NO176924C (es) |
NZ (2) | NZ219187A (es) |
OA (1) | OA08477A (es) |
PT (1) | PT84258B (es) |
SE (1) | SE468747B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0256713A3 (en) * | 1986-08-06 | 1989-02-15 | Merck & Co. Inc. | Therapeutic human antipseudomonas aeruginosa antibodies |
CA1341375C (en) * | 1988-10-12 | 2002-07-09 | Baxter International Inc. | Compositions and methods for the treatment and prevention of gram-negative bacterial infections |
DE3925161A1 (de) * | 1989-03-15 | 1990-09-27 | Boehringer Mannheim Gmbh | Monoklonale, gegen eca gerichtete antikoerper und ihre verwendung |
JPH0329196A (ja) * | 1989-05-09 | 1991-02-07 | Advanced Micro Devicds Inc | センス増幅器 |
US6315999B1 (en) | 1989-08-10 | 2001-11-13 | Solvay, S.A. | Pharmaceutical product for the treatment of sepsis |
GB8918232D0 (en) * | 1989-08-10 | 1989-09-20 | Opal Stephen M | Pharmaceutical product for the treatment of septic shock |
US20080139789A1 (en) * | 1990-10-22 | 2008-06-12 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection |
EP0635132B2 (en) * | 1992-03-19 | 2008-05-14 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
CA2153661A1 (en) * | 1993-01-12 | 1994-07-21 | Anthony George Gristina | Methods and compositions for the direct concentrated delivery of passive immunity |
US5510264A (en) * | 1993-09-28 | 1996-04-23 | Insight Biotech Inc. | Antibodies which bind meningitis related homologous antigenic sequences |
ATE474849T1 (de) * | 1998-04-14 | 2010-08-15 | Chugai Pharmaceutical Co Ltd | Neues cytokinartiges protein |
CA2694466A1 (en) * | 2007-07-23 | 2009-01-29 | Sanofi Pasteur Limited | Immunogenic polypeptides and monoclonal antibodies |
US8444983B2 (en) * | 2009-03-23 | 2013-05-21 | Quark Pharmaceuticals, Inc. | Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases |
BR112013013702A2 (pt) | 2010-12-03 | 2016-09-13 | Sanofi Pasteur Ltd | composição para imunização contra streptococcus pneumoniae |
US11168131B2 (en) | 2015-11-10 | 2021-11-09 | Visterra, Inc. | Antibody molecule-drug conjugates and uses thereof |
KR102697723B1 (ko) | 2017-01-18 | 2024-08-21 | 비스테라, 인크. | 항체 분자-약물 접합체 및 이의 용도 |
WO2021203024A1 (en) | 2020-04-03 | 2021-10-07 | Visterra, Inc. | Antibody molecule-drug conjugates and uses thereof |
US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4464465A (en) * | 1982-04-05 | 1984-08-07 | Genetic Systems Corporation | Cell-driven viral transfer in eukaryotes |
CA1262238C (en) * | 1982-09-30 | 1989-10-10 | HUMAN MONOCLONAL ANTIBODIES AGAINST BACTERIAL TOXINS | |
US4587121A (en) * | 1983-06-14 | 1986-05-06 | Miles Laboratories, Inc. | High titer Pseudomonas immune serum globulin |
US5179018A (en) * | 1983-10-14 | 1993-01-12 | Centocor, Inc. | Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria |
US4834975A (en) * | 1984-05-25 | 1989-05-30 | Genetics Corporation | Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production |
DE3426903A1 (de) * | 1984-07-20 | 1986-01-23 | Biotest Pharma GmbH, 6000 Frankfurt | Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten |
US4675287A (en) * | 1984-07-26 | 1987-06-23 | Scripps Clinic And Research Foundation | Monoclonal antibody directed to human ganglioside GD2 |
US4677070A (en) * | 1985-04-26 | 1987-06-30 | Cetus Corporation | Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use |
US4772464A (en) * | 1985-08-01 | 1988-09-20 | Miles Laboratories, Inc. | Protective antibodies to serotypic determinants of flagellar antigens |
US4777136A (en) * | 1985-09-27 | 1988-10-11 | The Regents Of The University Of California | Monoclonal antibody reactive with Pseudomonas Aeruginosa |
US4918163A (en) * | 1985-09-27 | 1990-04-17 | Pfizer Inc. | Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria |
NZ218499A (en) * | 1985-12-10 | 1990-04-26 | Genetic Systems Corp | Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods |
US4970070A (en) * | 1986-02-07 | 1990-11-13 | Genetic Systems Corporation | Protective monoclonal antibody compositions for infections due to group B streptococcus |
-
1987
- 1987-01-23 IL IL81370A patent/IL81370A/xx not_active IP Right Cessation
- 1987-01-30 CA CA000528543A patent/CA1339013C/en not_active Expired - Fee Related
- 1987-02-04 FR FR8701336A patent/FR2595946B1/fr not_active Expired - Fee Related
- 1987-02-05 NZ NZ219187A patent/NZ219187A/en unknown
- 1987-02-05 NZ NZ233920A patent/NZ233920A/en unknown
- 1987-02-06 IT IT8719292A patent/IT1207589B/it active
- 1987-02-06 ES ES8700289A patent/ES2009140A6/es not_active Expired
- 1987-02-06 NL NL8700286A patent/NL8700286A/nl not_active Application Discontinuation
- 1987-02-06 IE IE32087A patent/IE59627B1/en not_active IP Right Cessation
- 1987-02-06 NO NO870476A patent/NO176924C/no unknown
- 1987-02-06 CN CN198787102167A patent/CN87102167A/zh active Pending
- 1987-02-06 DK DK063187A patent/DK63187A/da not_active Application Discontinuation
- 1987-02-06 SE SE8700467A patent/SE468747B/sv not_active IP Right Cessation
- 1987-02-06 OA OA59063A patent/OA08477A/xx unknown
- 1987-02-06 DE DE19873703711 patent/DE3703711A1/de active Granted
- 1987-02-06 GR GR870194A patent/GR870194B/el unknown
- 1987-02-06 BE BE8700093A patent/BE1000967A5/fr not_active IP Right Cessation
- 1987-02-06 LU LU86761A patent/LU86761A1/fr unknown
- 1987-02-06 HU HU87470A patent/HU203583B/hu not_active IP Right Cessation
- 1987-02-06 JP JP62026188A patent/JP2645343B2/ja not_active Expired - Lifetime
- 1987-02-06 GB GB8702689A patent/GB2186592B/en not_active Expired - Fee Related
- 1987-02-06 FI FI870502A patent/FI94489C/fi not_active IP Right Cessation
- 1987-02-07 KR KR870000983A patent/KR870007697A/ko not_active Application Discontinuation
- 1987-02-09 AT AT0026287A patent/AT398781B/de not_active IP Right Cessation
- 1987-02-09 CH CH470/87A patent/CH672072A5/de not_active IP Right Cessation
- 1987-02-09 PT PT84258A patent/PT84258B/pt not_active IP Right Cessation
-
1992
- 1992-06-26 MX MX9203629A patent/MX9203629A/es unknown
-
1994
- 1994-09-02 US US08/300,118 patent/US5717071A/en not_active Expired - Fee Related
-
1995
- 1995-02-16 HK HK21795A patent/HK21795A/xx not_active IP Right Cessation
- 1995-06-05 US US08/464,495 patent/US5837541A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2009140A6 (es) | Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen. | |
SE8605295D0 (sv) | Monoclonal antibodies cross-reactive and crossprotective against p. aeruginosa serotypes | |
ATE248605T1 (de) | Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper | |
MXPA03005273A (es) | Anticuerpos producidos procarioticamente y sus usos. | |
PT730608E (pt) | Composicoes compreendendo hidratos de carbono e proeinas relacionadas pelo complemento e metodos para produzir e utilizar as referidas composicoes | |
CA2093667A1 (en) | Mouse monoclonal antibodies and uses thereof | |
NO962346L (no) | Humaniserte antistoffer og anvendelser derav | |
MY111682A (en) | Altered antibodies and their preparations. | |
DE59905954D1 (de) | Dialkylfumarate zur behandlung von autoimmunerkrankungen | |
IL127558A0 (en) | Hepatocyte growth factor receptor agonists and uses thereof | |
PT1053256E (pt) | Anticorpos para o receptor de morte 4 (dr4) e utilizações destes | |
FI924819A (fi) | Chimaera anti-icam-i-antikroppar foer maenniskobruk, foerfaranden foer deras framstaellning samt deras anvaendning | |
DK233385A (da) | Humant monoclonalt antistof, praeparat indeholdende antistoffer og cellelinie, der udskiller antistoffet | |
YU34196A (sh) | Peptidi i jedinjenja koja se vezuju za receptor | |
PT785948E (pt) | Analogos do factor de crescimento de queratinocitos | |
ATE257390T1 (de) | Verwendung eines bpi proteinproduktes als antithrombotisches mittel | |
AU2002223462A1 (en) | Use of cd28-specific monoclonal antibodies for stimulating blood cells that lackcd28 | |
RS49599B (sr) | Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija | |
SE9802937D0 (sv) | Novel compounds | |
GR3033253T3 (en) | Tri(platinum) complexes | |
SE8702734D0 (sv) | Monoclonal antibodies to pseudomonas aeruginosa flagella | |
FR2804027B1 (fr) | Utilisation d'anticorps monoclonaux anti-ferritines dans le traitement de certains cancers | |
IE861494L (en) | Protective human monoclonal antibodies to pseudomonas¹aeruginosa exotoxin a | |
ATE77243T1 (de) | E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom. | |
EP0836480A4 (en) | COMPOSITIONS THAT PROVIDE ADP-RIBOSYL TRANSFERASE ACTIVITY AND METHODS FOR THEIR PRODUCTION AND USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 20020401 |